Related Experiment Video
Updated: Jun 2, 2026

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
Published on: January 7, 2019
Characteristics and prognosis of patients requiring valve surgery during active infective endocarditis
Georges Fayad1, Guillaume Leroy, Patrick Devos
1Pôle de Chirurgie Cardiovasculaire, CHRU de Lille and Hôpital Cardiologique, CHRU de Lille, France. g.fayad@sfr.fr
Insights
Surgery for active infective endocarditis (IE) carries a high operative mortality rate. Prosthetic valve endocarditis (PVE) independently predicts worse outcomes, emphasizing the need for adequate antimicrobial therapy.
Area of Science:
- Cardiology
- Cardiac Surgery
- Infectious Diseases
Background:
- Active infective endocarditis (IE) often necessitates urgent valve surgery.
- Understanding operative mortality and associated factors is crucial for patient management.
Purpose of the Study:
- To characterize patients undergoing valve surgery for active IE.
- To identify factors influencing operative mortality in this high-risk group.
Main Methods:
- Retrospective analysis of 141 patients with active IE undergoing cardiac operations.
- Data collected on patient demographics, valve involvement, pathogens, and outcomes.
- Modified Duke criteria used for IE classification; active IE defined by surgery before antimicrobial completion.
Main Results:
- 16% operative mortality observed in the cohort.
- Native valve endocarditis was most common (87%).
- Prosthetic valve endocarditis (PVE) was an independent predictor of operative mortality (aOR=4.16).
Conclusions:
- Valve surgery for active IE is associated with significant operative mortality.
- PVE portends a poorer prognosis.
- Adequate antimicrobial therapy may improve outcomes in patients with active IE.
Background And Aim Of The Study:
The study aim was to describe the characteristics and operative mortality of patients requiring valve surgery during active infective endocarditis (IE).
Methods:
This retrospective analysis involved 141 surgically treated patients with active IE. All cardiac operations were performed by the same surgical team between January 1998 and July 2009. All patients had definite (n = 128) or possible (n = 13) endocarditis according to modified Duke criteria. The IE was considered active if surgery was required before completion of a standard course of antimicrobial therapy. Operative mortality included any death occurring within the same hospital admission as surgery.
Results:
Among the patients (108 males, 33 females; mean age 56.3 +/- 14.9 years), native valve endocarditis was present in 122 cases (87%). Multiple valve involvement was observed in 27 patients. The infected valves were the aortic (n = 81), mitral (n = 70), tricuspid (n = 15), or pulmonary (n = 2). The most common pathogens were staphylococci (n = 49), streptococci (n = 46) and enterococci (n = 27). The operative mortality was 16%. In univariate analysis, factors linked to operative mortality were age, prosthetic valve endocarditis (PVE) and inadequate antimicrobial therapy. In multivariate analysis, only PVE was an independent adverse predictor (adjusted Odds Ratio = 4.16; 95% confidence intervals 1.14-12.2; p = 0.01).
Conclusion:
Surgery for active IE is associated with a high mortality rate. The prognosis is impaired in patients with PVE, but might be improved by adequate antimicrobial therapy.
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis I: Introduction
Endocarditis IV: Nursing Management
Endocarditis II: Clinical Features of Infective Endocarditis
Mitral Stenosis III: Medical Management
Myocarditis III: Medical Management
